Company Information
Industry 制造业
Company Introduction 东北制药集团股份有限公司是一家以制造和销售化学原料药品、制剂药品为主业的企业.公司主要从事药品生产与流通。
Main Business 主要业务覆盖化学制药(原料药、制剂)、医药商业(批发、连锁)、医药工程(医药设计、制造安装)、生物医药(生物诊断试剂)等板块,形成了医药上下游产业及服务集群。
Legal Representative 郭建民
Top Executives
董事长:郭建民
董事:谭兆春,黄智华,郭建民
独立董事:商有光,姚辉,韩德民,王国栋
Top 5 Shareholder
Shareholder name Nature Holding Date
江西方大钢铁集团有限公司流通A股31.01%31/03/2024
辽宁方大集团实业有限公司流通A股23.03%31/03/2024
香港中央结算有限公司流通A股1.01%31/03/2024
方威流通A股0.85%31/03/2024
武恩波流通A股0.66%31/03/2024
Company Secretary 宋家纶
Solicitors 北京金诚同达律师事务所
Auditors 瑞华会计师事务所(特殊普通合伙)
Tel No 024-25806963
Fax No 024-25806400
Website www.nepharm.com.cn
Email dshbgs@nepharm.com.cn
Company Address
Register: 辽宁省沈阳市经济技术开发区昆明湖街8号
Office: 辽宁省沈阳市经济技术开发区昆明湖街8号
Listing Date 23/05/1996
Shares Capital
Shares Capital: 1,429,103,265
Total A Share: 1,429,103,265
Listed A Share: 1,374,263,742
Non-tradable A Share: 54,839,523
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.250
DPS(RMB)* ¥ 0.100
NBV Per Share(RMB)* ¥ 3.490
Market Capitalization(RMB) 6.624B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.